Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 856       

   Table of Contents      
CORRESPONDENCE
Year : 2015  |  Volume : 141  |  Issue : 1  |  Page : 125-126

Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects


Department of Infectious Diseases & Clinical Microbiology, Dr. Münif Islamoglu Kastamonu State Hospital, Kastamonu, Turkey

Date of Web Publication2-Apr-2015

Correspondence Address:
Hasan Tahsin Gozdas
Department of Infectious Diseases & Clinical Microbiology, Dr. Münif Islamoglu Kastamonu State Hospital, Kastamonu
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5916.154516

Rights and Permissions

How to cite this article:
Gozdas HT. Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects. Indian J Med Res 2015;141:125-6

How to cite this URL:
Gozdas HT. Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects. Indian J Med Res [serial online] 2015 [cited 2019 Jul 17];141:125-6. Available from: http://www.ijmr.org.in/text.asp?2015/141/1/125/154516

Sir,

I read with interest the article by Sugunan et al[1] on impact of hepatitis B immunization among the Nicobarese tribe. The authors investigated protective antibody response after hepatitis B vaccination in their study. I feel that several points in this study need to be clarified.

Hepatitis B infection has been reported to be hyperendemic in Nicobarese where this study was conducted. As per the inclusion criteria, subjects negative for both HBsAg and Anti-HBs were included in the study. However, hepatitis B core antibody (anti-HBc) status of the study population was not mentioned. This condition could be a confounding factor. Because hepatitis B vaccine is not recommended for isolated anti-HBc positive subjects (HBsAg and anti-HBs negative) living in highy endemic areas due to the high probability of previous exposure to hepatitis B infection [2] . Isolated anti-HBc positivity might be present in these subjects who were at high risk for prior exposure to hepatitis B infection. Antibody response after hepatitis B vaccination may be different in isolated anti-Hbc positive subjects from that of naive subjects [3] . In addition, primary anti-HBs response develops when anti-HBc was positive at a low titre; whereas secondary or anamnestic antibody response develops when anti-HBc was positive at a high titre [3],[4] . Subjects enrolled in this study might be heterogeneous in terms of anti-Hbc status due to sampling error. Further in this study [1] , protective antibody level was tested one month after each vaccine dose and after the completion of vaccine series at second, third and fifth year. As understood from the Figure, protective antibody level after the third vaccine dose was tested at sixth month rather than the seventh month. However, as mentioned in the article, protective levels should have been checked one month after each vaccine dose (after the third dose of vaccine at seventh month not at sixth month). I think there is a typographical error in the figure.

 
   References Top

1.
Sugunan AP, Bhattacharya H, Bhattacharya D, Mandal A, Ghosal SR, Rao RC, et al. Impact of hepatitis B immunization among the Nicobarese tribe antibody titres & seroprotection five years after vaccination. Indian J Med Res 2014; 139 : 427-30.  Back to cited text no. 1
    
2.
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50 : 661-2.  Back to cited text no. 2
    
3.
McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103 : 590-4.  Back to cited text no. 3
    
4.
Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988; 8 : 766-70.  Back to cited text no. 4
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed392    
    Printed8    
    Emailed0    
    PDF Downloaded175    
    Comments [Add]    

Recommend this journal